Pzena Investment Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
24,507
+5,684
+30% +$301K ﹤0.01% 132
2026
Q1
$1.04M Buy
18,823
+5,379
+40% +$291K ﹤0.01% 140
2025
Q4
$659K Buy
13,444
+4,727
+54% +$220K ﹤0.01% 142
2025
Q3
$376K Buy
8,717
+1,207
+16% +$47.1K ﹤0.01% 141
2025
Q2
$288K Buy
+7,510
New +$287K ﹤0.01% 142

Other funds holding GSK

Pzena Investment Management's GSK Position: Q2 2026 in Review

Pzena Investment Management increased its GSK (GSK) stake by 30% in Q2 2026, buying an estimated $301K and bringing the position to 24,507 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #132.

Pzena Investment Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. 748 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Pzena Investment Management held 24,507 shares of GSK worth $1.28M as of Q2 2026.
  • Pzena Investment Management bought 5,684 GSK shares in Q2 2026, an estimated $301K.
  • GSK made up ﹤0.01% of Pzena Investment Management's portfolio in Q2 2026, its #132 holding.
  • Pzena Investment Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • 748 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Pzena Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.